Hello, welcome to Tosun!
会员中心

Product introduction:

Ezemeb is used for the treatment of LDL-C elevation in patients with primary hyperlipidemia or mixed hyperlipidemia that cannot be fully controlled by diet alone.

市场价:

  • Product information
  • 产品描述
  • 参数配置


1、 Product introduction

Chinese Name

English Name

Declaration Type

Department

Reportable Dosage Form

Declaration Progress

Strength

CAS
依折麦布Ezetimibe5+4HypolipidemiaTablet, Capsule

Ready to declare

Tablet:10mg

Capsule:20mg、40mg

163222-33-1

Indication】

      Primary hypercholesterolemia. It can be used alone or in combination with HMG CoA reducing mould inhibitors (statins) to treat primary (heterozygous familial or non familial) hypercholesterolemia. It can reduce TC, LDL-C and apob. Homozygous familial hypercholesterolemia (hofh) can be used in combination with statins as an adjuvant therapy for other lipid-lowering therapies (such as LDL-C plasma separation and exchange method), or to reduce TC and LDL-C levels in patients with hofh when other lipid-lowering therapies are ineffective. Homozygous sitosteronemia (or phytosterol blood syndrome) this product is used as an adjunctive treatment in addition to diet control to reduce.


Reportable Dosage Form &Strength

Tablet:10mg

Capsule:20mg、40mg


Mechanism of Action

  Cholesterol absorption inhibitors.      


Development Progress】      

Ready to declare


二、Domestic Declaration



Declaration Type

Reportable Dosage Form

Number of Declared Preparations

Number of Existing Preparation Enterprises

5+4Tablet, Capsule

Tablet: 1 imported, 15 domestic;

Compound tablet: 1 imported, 10 domestic

Tablet: 1 imported; 

Compound tablet: 2 imported




 Brinzolamide 布林佐胺 CAS号:138890-62-7

Guangzhou Tosun Pharmaceutical Ltd

FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663

Tel: +86-20-66392521; Fax: +86-20-66392525

Ezemeb is used for the treatment of LDL-C elevation in patients with primary hyperlipidemia or mixed hyperlipidemia that cannot be fully controlled by diet alone.

The first cholesterol absorption inhibitor

热门关键词: 进口原料药代理 印度进口原料药 原料药关联审评 进口药品注册代理 国内参比制剂 美国参比制剂 原料药注册服务 原料药联合申报 原料药供应商
Copyright ©2020 Guangzhou Tosun Pharmaceutical Ltd 粤ICP备16102594号-2
MapsXML Maps  Maps
Phone

(86)18922121079

(86)18026299762

TOP